Lausanne University Hospitals
Lausanne, Canton of Vaud, 1011, Switzerland
NCT Number: NCT03534752
This is a retrospective study aimed at establishing a database of the current health of adult patients with IEM in the French-speaking part of Switzerland. .
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Lausanne, Canton of Vaud, 1011, Switzerland
Background Inborn errors of metabolism (IEMs) are a group of rare disorders caused by genetic mutations that affect enzymes of intermediary metabolism. Because adult with IEMs has become an emerging and challenging group in Switzerland, this study is intended to assess the actual situation of adult patients with IEM in the French-speaking part of Switzerland, namely their age, their sex, their diagnosis, age at disease onset and their clinical outcome including complications of the disease.
All adult patients with a biochemical and/or genetic diagnosis of IEM followed at the adult metabolic clinic from the Lausanne University Hospital and Geneva University Hospital between 01.10.2013 to 31.12.2017 will be included in the study. In addition, investigators will also include the patients referred to the clinic for suspicion of IEM and determinate if the investigation confirmed an IEM disease. Electronic and paper patient charts will be reviewed for clinical features, biochemical investigations, molecular genetic testing, diagnostic imaging, treatment and long-term outcome. All data will be entered in an Excel database.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: First visit
Clinical outcome
Time frame: First visit
Clinical outcome
Time frame: 4 years
Clinical outcome including acute liver failure, nephropathy, metabolic acidosis, ophthalmologic anomalies, epilepsy, encephalopathy, myopathy, neuropathy, diabetes
Time frame: 4 years
Treatment specific to each diseases including ammonia scavenger, enzyme replacement therapy, carnitine, ubiquinone, vitamins, specific diet, dialysis, specific metabolic formula
Time frame: 4 years
Clinical outcome
Time frame: 4 years
Clinical Outcome
Time frame: First visit
Demography outcome
Time frame: 4 years
Radiological Imaging description of spleen and/or liver when available (size, echostructure)
Time frame: 4 years
Radiological Imaging description of brain, abdomen and bone when available
Time frame: 4 years
Radiological Imaging description of bone including T-score when available
Time frame: 4 years
Laboratory including blood concentration of chitotriosidase and Galactose-1-Phosphate
Time frame: 4 years
Laboratory including blood concentration of sodium, potassium, liver function tests, creatinine, uric acid, urea, amino acids, acylcarnitine profile, methylmalonate, total homocysteine and urine concentration of organic acids
Time frame: 4 years
Laboratory (blood count, international normalized ratio, prothrombin time)
Time frame: 4 years
Enzyme activity of deficient enzyme when available for lysosomal storage diseases, mucopolysaccharidoses, cobalamin deficiency, diseases, classical homocystinuria
Time frame: 4 years
Laboratory including mutation results confirming the molecular origin of the disease when available
Time frame: 4 years
Demography outcome
Time frame: 4 years
Demography outcome
University of Lausanne
Other
Clinical Characteristics of Adult Patients With Inborn Errors of Metabolism in French-speaking Switzerland
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02322177
Acidemias, Amino Acid Metabolism, Inborn Errors
Bethesda, Maryland, United States
View Trial DetailsNCT04399694
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Durham, North Carolina, United States
View Trial DetailsNCT02349906
Bone Marrow Diseases, Bone Marrow Failure Disorders
Prague, Czechia
View Trial DetailsNCT03548779
Autism Spectrum Disorder, Brain Diseases
Asheville, North Carolina, United States
View Trial Details